Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 138

Related Citations for PubMed (Select 21480320)

1.
2.

Subset of Suz12/PRC2 target genes is activated during hepatitis B virus replication and liver carcinogenesis associated with HBV X protein.

Studach LL, Menne S, Cairo S, Buendia MA, Hullinger RL, Lefrançois L, Merle P, Andrisani OM.

Hepatology. 2012 Oct;56(4):1240-51. doi: 10.1002/hep.25781.

3.

Polo-like kinase 1 activated by the hepatitis B virus X protein attenuates both the DNA damage checkpoint and DNA repair resulting in partial polyploidy.

Studach L, Wang WH, Weber G, Tang J, Hullinger RL, Malbrue R, Liu X, Andrisani O.

J Biol Chem. 2010 Sep 24;285(39):30282-93. doi: 10.1074/jbc.M109.093963. Epub 2010 Jul 12.

4.

Polo-like kinase 1 inhibition suppresses hepatitis B virus X protein-induced transformation in an in vitro model of liver cancer progression.

Studach LL, Rakotomalala L, Wang WH, Hullinger RL, Cairo S, Buendia MA, Andrisani OM.

Hepatology. 2009 Aug;50(2):414-23. doi: 10.1002/hep.22996.

5.

Deregulation of epigenetic mechanisms by the hepatitis B virus X protein in hepatocarcinogenesis.

Andrisani OM.

Viruses. 2013 Mar 18;5(3):858-72. doi: 10.3390/v5030858. Review.

6.
7.

Inhibitory role of Plk1 in the regulation of p73-dependent apoptosis through physical interaction and phosphorylation.

Koida N, Ozaki T, Yamamoto H, Ono S, Koda T, Ando K, Okoshi R, Kamijo T, Omura K, Nakagawara A.

J Biol Chem. 2008 Mar 28;283(13):8555-63. doi: 10.1074/jbc.M710608200. Epub 2008 Jan 3.

8.

Inhibition of hepatitis B virus replication by the host zinc finger antiviral protein.

Mao R, Nie H, Cai D, Zhang J, Liu H, Yan R, Cuconati A, Block TM, Guo JT, Guo H.

PLoS Pathog. 2013;9(7):e1003494. doi: 10.1371/journal.ppat.1003494. Epub 2013 Jul 11.

9.

Polo-like kinase 1 depletion induces DNA damage in early S prior to caspase activation.

Yim H, Erikson RL.

Mol Cell Biol. 2009 May;29(10):2609-21. doi: 10.1128/MCB.01277-08. Epub 2009 Mar 16.

10.

Krüppel-like factor 15 activates hepatitis B virus gene expression and replication.

Zhou J, Tan T, Tian Y, Zheng B, Ou JH, Huang EJ, Yen TS.

Hepatology. 2011 Jul;54(1):109-21. doi: 10.1002/hep.24362.

11.

Defective DNA damage response and repair in liver cells expressing hepatitis B virus surface antigen.

Chung YL.

FASEB J. 2013 Jun;27(6):2316-27. doi: 10.1096/fj.12-226639. Epub 2013 Feb 26.

12.
13.

Hepatitis B virus X protein differentially regulates cell cycle progression in X-transforming versus nontransforming hepatocyte (AML12) cell lines.

Lee S, Tarn C, Wang WH, Chen S, Hullinger RL, Andrisani OM.

J Biol Chem. 2002 Mar 8;277(10):8730-40. Epub 2001 Dec 26.

14.

Dissection of cell context-dependent interactions between HBx and p53 family members in regulation of apoptosis: a role for HBV-induced HCC.

Knoll S, Fürst K, Thomas S, Villanueva Baselga S, Stoll A, Schaefer S, Pützer BM.

Cell Cycle. 2011 Oct 15;10(20):3554-65. doi: 10.4161/cc.10.20.17856. Epub 2011 Oct 15.

15.

Polo-like kinase 1 is involved in hepatitis C virus replication by hyperphosphorylating NS5A.

Chen YC, Su WC, Huang JY, Chao TC, Jeng KS, Machida K, Lai MM.

J Virol. 2010 Aug;84(16):7983-93. doi: 10.1128/JVI.00068-10. Epub 2010 Jun 9.

17.

Long-term downregulation of Polo-like kinase 1 increases the cyclin-dependent kinase inhibitor p21(WAF1/CIP1).

Kreis NN, Sommer K, Sanhaji M, Krämer A, Matthess Y, Kaufmann M, Strebhardt K, Yuan J.

Cell Cycle. 2009 Feb 1;8(3):460-72. Epub 2009 Feb 18.

18.

Hepatitis B virus X protein increases the Cdt1-to-geminin ratio inducing DNA re-replication and polyploidy.

Rakotomalala L, Studach L, Wang WH, Gregori G, Hullinger RL, Andrisani O.

J Biol Chem. 2008 Oct 17;283(42):28729-40. doi: 10.1074/jbc.M802751200. Epub 2008 Aug 8.

19.

Genistein-induced neuronal apoptosis and G2/M cell cycle arrest is associated with MDC1 up-regulation and PLK1 down-regulation.

Ismail IA, Kang KS, Lee HA, Kim JW, Sohn YK.

Eur J Pharmacol. 2007 Dec 1;575(1-3):12-20. Epub 2007 Jul 28.

PMID:
17706963
20.

Hepatitis B virus X protein via the p38MAPK pathway induces E2F1 release and ATR kinase activation mediating p53 apoptosis.

Wang WH, Hullinger RL, Andrisani OM.

J Biol Chem. 2008 Sep 12;283(37):25455-67. doi: 10.1074/jbc.M801934200. Epub 2008 Jul 7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk